These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19766430)

  • 1. In vivo selection of carbapenem-resistant Klebsiella pneumoniae by OmpK36 loss during meropenem treatment.
    Song W; Suh B; Choi JY; Jeong SH; Jeon EH; Lee YK; Hong SG; Lee K
    Diagn Microbiol Infect Dis; 2009 Dec; 65(4):447-9. PubMed ID: 19766430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.
    Webster DP; Gaulton T; Woodford N; Pike R; Turton J; Perry C; Bowler IC
    Int J Antimicrob Agents; 2010 Dec; 36(6):575-6. PubMed ID: 20869852
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy.
    Findlay J; Hamouda A; Dancer SJ; Amyes SG
    Clin Microbiol Infect; 2012 Feb; 18(2):140-6. PubMed ID: 21745255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
    Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
    Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
    Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase.
    Cuzon G; Naas T; Guibert M; Nordmann P
    Int J Antimicrob Agents; 2010 Mar; 35(3):265-8. PubMed ID: 20034767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
    Palasubramaniam S; Muniandy S; Navaratnam P
    J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.
    Bidet P; Burghoffer B; Gautier V; Brahimi N; Mariani-Kurkdjian P; El-Ghoneimi A; Bingen E; Arlet G
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3562-5. PubMed ID: 16048985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo selection of OmpK35-deficient mutant after cefuroxime therapy for primary liver abscess caused by Klebsiella pneumoniae.
    Lee CH; Chia JH; Chu C; Wu TL; Liu JW; Su LH
    J Antimicrob Chemother; 2006 Oct; 58(4):857-60. PubMed ID: 16880175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem-resistance in Klebsiella pneumoniae in Malaysia due to loss of OmpK36 outer membrane protein coupled with AmpC hyperproduction.
    Palasubramaniam S; Karunakaran R; Gin GG; Muniandy S; Parasakthi N
    Int J Infect Dis; 2007 Sep; 11(5):472-4. PubMed ID: 17337225
    [No Abstract]   [Full Text] [Related]  

  • 13. Meropenem-Vaborbactam Resistance Selection, Resistance Prevention, and Molecular Mechanisms in Mutants of KPC-Producing Klebsiella pneumoniae.
    Sun D; Rubio-Aparicio D; Nelson K; Dudley MN; Lomovskaya O
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 29038260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.
    Kim SY; Park YJ; Yu JK; Kim HS; Park YS; Yoon JB; Yoo JY; Lee K
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):85-91. PubMed ID: 16854555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6.
    Shigemoto N; Kuwahara R; Kayama S; Shimizu W; Onodera M; Yokozaki M; Hisatsune J; Kato F; Ohge H; Sugai M
    Diagn Microbiol Infect Dis; 2012 Jan; 72(1):109-12. PubMed ID: 22078906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of IS1R and IS10R elements inserted into ompk36 porin gene of two multidrug-resistant Klebsiella pneumoniae hospital strains.
    Lev AI; Astashkin EI; Shaikhutdinova RZ; Platonov ME; Kartsev NN; Volozhantsev NV; Ershova ON; Svetoch EA; Fursova NK
    FEMS Microbiol Lett; 2017 May; 364(10):. PubMed ID: 28402509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
    Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
    J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Shields RK; Nguyen MH; Press EG; Chen L; Kreiswirth BN; Clancy CJ
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversion to susceptibility of a carbapenem-resistant clinical isolate of Klebsiella pneumoniae producing KPC-3.
    Villa L; Capone A; Fortini D; Dolejska M; Rodríguez I; Taglietti F; De Paolis P; Petrosillo N; Carattoli A
    J Antimicrob Chemother; 2013 Nov; 68(11):2482-6. PubMed ID: 23800906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
    Conejo MC; Hernández JR; Pascual A
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.